Restructuring to hit pharmaceutical sector

Korea’s pharmaceutical sector is headed for a fresh round of restructuring, with many small- and medium-size companies pushing employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook.

Currently, Korean pharmaceutical companies are feeling pressure from all sides. Relying too much on selling cheap generic drugs instead of developing original drugs...